Terrie Curran's Net Worth
Terrie Curran's net worth is estimated to be at least $2,818,818.79 as of 11/20/2024. CoreStreet's estimation of Terrie Curran's net worth is based on their sale of stock and current holding of stock.
Terrie Curran is Director at Arcutis Biotherapeutics Inc. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 8,687 units of ARQT stock on 11/11/2024. Their biggest sale was on 09/18/2019 when they sold 11,338 units of Bristol-Myers Squibb Company stock for $1,114,185.26. They typically trade 1 times per year.
Total value of insider buys:
- $252,931.58
Total value of insider sells:
- $2,565,887.21
Most recent insider trade:
- Nov. 11, 2024
Terrie Curran's Insider Trading History
Arcutis Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Nov. 11, 2024 | Director | 8,687 | $10.85 | Sell | $94,253.95 |
Phathom Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
July 15, 2024 | Insider | 33,848 | $11.72 | Sell | $396,698.56 |
March 22, 2024 | Insider | 16,851 | $9.11 | Sell | $153,512.61 |
April 6, 2023 | Insider | 12,919 | $7.82 | Buy | $101,026.58 |
March 1, 2023 | Insider | 1,436 | $8.54 | Sell | $12,263.44 |
Jan. 20, 2023 | Insider | 5,821 | $8.20 | Sell | $47,732.20 |
May 13, 2022 | Insider | 20,500 | $7.41 | Buy | $151,905.00 |
March 22, 2021 | Insider | 11,513 | $43.32 | Sell | $498,743.16 |
Bristol-Myers Squibb Company | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Sept. 18, 2019 | Insider | 11,338 | $98.27 | Sell | $1,114,185.26 |
Sept. 25, 2017 | Insider | 1,727 | $143.89 | Sell | $248,498.03 |